Skip to content
The Policy VaultThe Policy Vault

Xarelto — Medica

Atrial fibrillation (or atrial flutter)

Initial criteria

  • Patient is age ≥ 18 years
  • If rivaroxaban oral suspension is being requested, patient is unable to have Xarelto tablets appropriately administered

Approval duration

1 year